FDG-PET in the Diagnosis of Autoimmune Encephalitis
ConditionAutoimmune Encephalitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Milano Bicocca
About this trial
The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is:
•is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.
Eligibility criteria
Qualifiers
Diagnosis of autoimmune encephalitis according to clinical criteria
Brain magnetic resonance imaging performed between clinical presentation and treatment
Cerebrospinal fluid analysis performed between clinical presentation and treatment
Brain FDG-PET performed between clinical presentation and treatment
Disqualifiers
Refusal to give consent for the study
Trial design
Treatments tested in this trial
- FDG-PET
Treatment groups
90 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov